Plasmodium vivax resistance to chloroquine in Madagascar: Clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 12, 2008, Pages 4233-4240

  Barnadas, Céline ^a,d   Ratsimbasoa, Arsène ^c   Tichit, Magali ^b   Bouchier, Christiane ^b   Jahevitra, Martial ^c   Picot, Stéphane ^a   Ménard, Didier ^c  

^a UNIVERSITÉ LYON 1   (France)

^b INSTITUT PASTEUR   (France)

^c INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^d Parasitology and Tropical Medicine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; CHLOROQUINE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FOLLOW UP; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; NUCLEOTIDE SEQUENCE; PLASMODIUM VIVAX; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; FEMALE; HUMANS; MADAGASCAR; MALARIA, VIVAX; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION; PARASITIC SENSITIVITY TESTS; PLASMODIUM VIVAX; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; SENTINEL SURVEILLANCE; SEQUENCE ANALYSIS, DNA; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 57049181505     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00578-08     Document Type: Article

References (48)

1. Baird, J. K., H. Basri, Purnomo, M. J. Bangs, B. Subianto, L. C. Patchen, and S. L. Hoffman. 1991. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 44:547-552.
2. Baird, J. K., M. F. Sustriayu Nalim, H. Basri, S. Masbar, B. Leksana, E. Tjitra, R. M. Dewi, M. Khairani, and F. S. Wignall. 1996. Survey of resistance to chloroquine by Plasmodium vivax in Indonesia. Trans. R. Soc. Trop. Med. Hyg. 90:409-411.
3. Barnadas, C., A. Ratsimbasoa, H. Ranaivosoa, D. Ralaizandry, D. Raveloariseheno, V. Rabekotonorina, S. Picot, and D. Ménard. 2007. Prevalence and chloroquine sensitivity of Plasmodium malariae in Madagascar. Am. J. Trop. Med. Hyg. 77:1039-1042.
4. Barnadas, C., M. Tichit, C. Bouchier, A. Ratsimbasoa, L. Randrianasolo, R. Raherinjafy, M. Jahevitra, S. Picot, and D. Ménard. 2008. Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine. Malar. J. 7:35.
5. Brega, S., B. Meslin, F. de Monbrison, C. Severini, L. Gradoni, R. Udomsangpetch, I. Sutanto, F. Peyron, and S. Picot. 2005. Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity. J. Infect. Dis. 191:272-277.
6. Bruce, M. C., M. R. Galinski, J. W. Barnwell, G. Snounou, and K. P. Day. 1999. Polymorphism at the merozoite surface protein-3α locus of Plasmodium vivax: global and local diversity. Am. J. Trop. Med. Hyg. 61:518-525.
7. Cattani, J. A., J. L. Tulloch, H. Vrbova, D. Jolley, F. D. Gibson, J. S. Moir, P. F. Heywood, M. P. Alpers, A. Stevenson, and R. Clancy. 1986. The epidemiology of malaria in a population surrounding Madang, Papua New Guinea. Am. J. Trop. Med. Hyg. 35:3-15.
8. Chen, N., A. Auliff, K. Rieckmann, M. Gatton, and Q. Cheng. 2007. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J. Infect. Dis. 195:934-941.
9. Cui, L., A. A. Escalante, M. Imwong, and G. Snounou. 2003. The genetic diversity of Plasmodium vivax populations. Trends Parasitol. 19:220-226.
10. de Monbrison, F., C. Angei, A. Staal, K. Kaiser, and S. Picot. 2003. Simultaneous identification of the four human Plasmodium species and quantification of Plasmodium DNA load in human blood by real-time polymerase chain reaction. Trans. R. Soc. Trop. Med. Hyg. 97:387-390.
11. Dua, V. K., P. K. Kar, and V. P. Sharma. 1996. Chloroquine resistant Plasmodium vivax malaria in India. Trop. Med. Int. Health 1:816-819.
12. Fryauff, D. J., S. Tuti, A. Mardi, S. Masbar, R. Patipelohi, B. Leksana, K. C. Kain, M. J. Bangs, T. L. Richie, and J. K. Baird. 1998. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. Am. J. Trop. Med. Hyg. 59:513-518.
13. Goodman, S. M., and P. B. Benstead. 2003. The natural history of Madagascar. University of Chicago Press, Chicago, IL.
14. Guerra, C. A., R. W. Snow, and S. I. Hay. 2006. Mapping the global extent of malaria in 2005. Trends Parasitol. 22:353-358.
15. Guthmann, J. P., A. Pittet, A. Lesage, M. Imwong, N. Lindegardh, M. Min Lwin, T. Zaw, A. Annerberg, X. de Radigues, and F. Nosten. 2008. Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar. Trop. Med. Int. Health 13:91-98.
16. Hall, T. A. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
17. Hay, S. I., C. A. Guerra, A. J. Tatem, A. M. Noor, and R. W. Snow. 2004. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect. Dis. 4:327-336.
18. Imwong, M., S. Pukrittayakamee, A. C. Gruner, L. Renia, F. Letourneur, S. Looareesuwan, N. J. White, and G. Snounou. 2005. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Malar. J. 4:20.
19. Imwong, M., G. Snounou, S. Pukrittayakamee, N. Tanomsing, J. R. Kim, A. Nandy, J. P. Guthmann, F. Nosten, J. Carlton, S. Looareesuwan, S. Nair, D. Sudimack, N. P. Day, T. J. Anderson, and N. J. White. 2007. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J. Infect. Dis. 195:927-933.
20. Institut National de la Statistique et ORC Macro. 2005. Enquête Démographique et de Santé de Madagascar 2003-2004. INSTAT et ORC Macro, Calverton, MD. http://pdf.dec.org/pdf_docs/Pnadd779.pdf.
21. Kurcer, M. A., Z. Simsek, and Z. Kurcer. 2006. The decreasing efficacy of chloroquine in the treatment of Plasmodium vivax malaria, in Sanliurfa, south-eastern Turkey. Ann. Trop. Med. Parasitol. 100:109-113.
22. Luxemburger, C., M. van Vugt, S. Jonathan, R. McGready, S. Looareesuwan, N. J. White, and F. Nosten. 1999. Treatment of vivax malaria on the western border of Thailand. Trans. R. Soc. Trop. Med. Hyg. 93:433-438.
23. Marfurt, J., I. Mueller, A. Sie, P. Maku, M. Goroti, J. C. Reeder, H. P. Beck, and B. Genton. 2007. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea. Am. J. Trop. Med. Hyg. 77:947-954.
24. Marlar-Than, Myat-Phone-Kyaw, Aye-Yu-Soe, Khaing-Khaing-Gyi, Ma-Sabai, and Myint-Oo. 1995. Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Trans. R. Soc. Trop. Med. Hyg. 89:307-308.
25. Medicines for Malaria Venture and World Health Organization. 2008. Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. Informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organization, 29-31 May 2007, Amsterdam, The Netherlands. World Health Organization, Geneva, Switzerland. http://www.mmv.org/IMG/pdf/ MalariaGenotyping2.pdf.
26. Ménard, D., A. Ratsimbasoa, M. Randrianarivelojosia, L. Rabarijaona, L. Raharimalala, O. Domarle, L. Randrianasolo, A. Randriamanantena, M. Jahevitra, V. Andriantsoanirina, M. A. Rason, R. Raherinjafy, E. Rakotomalala, L. Tuseo, and A. Raveloson. 2008. Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up-dated baseline data from randomized and multi-site clinical trials. Malar. J. 7:55.
27. Mendis, K., B. J. Sina, P. Marchesini, and R. Carter. 2001. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64:97-106.
28. Murphy, G. S., H. Basri, Purnomo, E. M. Andersen, M. J. Bangs, D. L. Mount, J. Gorden, A. A. Lal, A. R. Purwokusumo, S. Harjosuwarno, et al. 1993. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 341:96-100.
29. Myat-Phone-Kyaw, Myint-Oo, Myint-Lwin, Thaw-Zin, Kyin-Hla-Aye, and Nwe-Nwe-Yin. 1993. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Trans. R. Soc. Trop. Med. Hyg. 87:687.
30. Nomura, T., J. M. Carlton, J. K. Baird, H. A. del Portillo, D. J. Fryauff, D. Rathore, D. A. Fidock, X. Su, W. E. Collins, T. F. McCutchan, J. C. Wootton, and T. E. Wellems. 2001. Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. J. Infect. Dis. 183:1653-1661.
31. Phan, G. T., P. J. de Vries, B. Q. Tran, H. Q. Le, N. V. Nguyen, T. V. Nguyen, S. H. Heisterkamp, and P. A. Kager. 2002. Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam. Trop. Med. Int. Health 7:858-864.
32. Phillips, E. J., J. S. Keystone, and K. C. Kain. 1996. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin. Infect. Dis. 23:1171-1173.
33. Price, R. N., E. Tjitra, C. A. Guerra, S. Yeung, N. J. White, and N. M. Anstey. 2007. Vivax malaria: neglected and not benign. Am. J. Trop. Med. Hyg. 77:79-87.
34. Rason, M. A., H. B. Andrianantenaina, F. Ariey, A. Raveloson, O. Domarle, and M. Randrianarivelojosia. 2007. Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains. Am. J. Trop. Med. Hyg. 76:1079-1083.
35. Ratcliff, A., H. Siswantoro, E. Kenangalem, M. Wuwung, A. Brockman, M. D. Edstein, F. Laihad, E. P. Ebsworth, N. M. Anstey, E. Tjitra, and R. N. Price. 2007. Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia. Trans. R. Soc. Trop. Med. Hyg. 101:351-359.
36. Ratsimbasoa, A., M. Randrianarivelojosia, P. Millet, J. L. Soares, L. Rabarijaona, B. Rakotoson, D. Malvy, and D. Ménard. 2006. Use of pre-packaged chloroquine for the home management of presumed malaria in Malagasy children. Malar. J. 5:79.
37. Rieckmann, K. H., D. R. Davis, and D. C. Hutton. 1989. Plasmodium vivax resistance to chloroquine? Lancet ii:1183-1184.
38. Sá, J. M., T. Nomura, J. Neves, J. K. Baird, T. E. Wellems, and H. A. del Portillo. 2005. Plasmodium vivax: allele variants of the mdr1 gene do not associate with chloroquine resistance among isolates from Brazil, Papua, and monkey-adapted strains. Exp. Parasitol. 109:256-259.
39. Sá, J. M., M. M. Yamamoto, C. Fernandez-Becerra, M. F. de Azevedo, J. Papakrivos, B. Naude, T. E. Wellems, and H. A. Del Portillo. 2006. Expression and function of pvcrt-o, a Plasmodium vivax ortholog of pfcrt, in Plasmodium falciparum and Dictyostelium discoideum. Mol. Biochem. Parasitol. 150:219-228.
40. Singh, N., S. S. Mishra, M. P. Singh, and V. P. Sharma. 2000. Seasonality of Plasmodium vivax and P. falciparum in tribal villages in central India (1987-1995). Ann. Trop. Med. Parasitol. 94:101-112.
41. Soto, J., J. Toledo, P. Gutierrez, M. Luzz, N. Llinas, N. Cedeno, M. Dunne, and J. Berman. 2001. Plasmodium vivax clinically resistant to chloroquine in Colombia. Am. J. Trop. Med. Hyg. 65:90-93.
42. Sumawinata, I. W., Bernadeta, B. Leksana, A. Sutamihardja, Purnomo, B. Subianto, Sekartuti, D. J. Fryauff, and J. K. Baird. 2003. Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. Am. J. Trop. Med. Hyg. 68:416-420.
43. Suwanarusk, R., B. Russell, M. Chavchich, F. Chalfein, E. Kenangalem, V. Kosaisavee, B. Prasetyorini, K. A. Piera, M. Barends, A. Brockman, U. Lek-Uthai, N. M. Anstey, E. Tjitra, F. Nosten, Q. Cheng, and R. N. Price. 2007. Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. PLoS ONE 2:e1089.
44. Tjitra, E., J. Baker, S. Suprianto, Q. Cheng, and N. M. Anstey. 2002. Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations. Antimicrob. Agents Chemother. 46:3947-3953.
45. Udomsangpetch, R., S. Somsri, T. Panichakul, K. Chotivanich, J. Sirichaisinthop, Z. Yang, L. Cui, and J. Sattabongkot. 2007. Short-term in vitro culture of field isolates of Plasmodium vivax using umbilical cord blood. Parasitol. Int. 56:65-69.
46. UNICEF. 2000. Multiple Indicator Cluster Survey (MICS) 2000, Madagascar, rapport complet. http://www.childinfo.org/files/madagascar.pdf.
47. Wellems, T. E., and C. V. Plowe. 2001. Chloroquine-resistant malaria. J. Infect. Dis. 184:770-776.
48. World Health Organization. 2001. Monitoring antimalarial drug resistance. Report of a WHO consultation, Geneva, December 2001. Document WHO/CDS/RBM 2002.39. WHO, Geneva, Switzerland.